Dr. Daniel Z. Uslan, MD

Dr. Uslan practices at Ronald Reagan UCLA Medical Center in Los Angeles, California, part of University of California Health.

Dr. Uslan's NPI, 1952373938, was assigned on February 3, 2006. Dr. Uslan graduated from Keck School of Medicine of USC in 2001. Dr. Uslan holds California license A97197.

Dr. Uslan's primary practice is Ronald Reagan UCLA Medical Center, at 757 Westwood Plaza, Los Angeles, CA 90095 in Los Angeles County. The practice phone is (310) 825-6301.

Dr. Uslan's primary practice is Ronald Reagan UCLA Medical Center in Los Angeles, California, part of University of California Health. The medical group on file is UCLA Medical Group. Dmand AI also links Dr. Uslan to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Uslan practices, 2 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Uslan's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Uslan is board certified in infectious disease by the American Board of Internal Medicine. Dmand AI has Dr. Uslan's licenses on file in 2 states: California and Minnesota.

Dmand AI lists hepatitis c and pneumonia among the conditions Dr. Uslan treats.

CMS data shows 141 Medicare services from Dr. Uslan across 3 procedure codes in 2024, for 94 Medicare patients. Medicare paid $14,399 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 94 Medicare patients who saw Dr. Uslan in 2024. The largest group is 65 to 74, with 34 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 44% are also on Medicaid. Their average risk score is 3.59, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Uslan's median patient age at 51, with 44% women.

In 2024, Dr. Uslan wrote 104 Medicare Part D claims for 49 patients. 45% of them were for generic drugs. CMS names the drug for 51 of them, across 4 drugs with 11 or more claims each, at $7,525 in total drug cost. In 2023, CMS named 12 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Uslan for performance year 2024, reported as part of a group. Dr. Uslan accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 14 papers to Dr. Uslan, published from 2012 to 2017. Dr. Uslan's most frequent co-authors are Stephan B. Danik, MD, Jordan M. Prutkin, MD, MHS and Muhammad Rizwan Sohail, MD.

CMS Open Payments shows 13 general payments to Dr. Uslan from 1 drug or device company from 2017 to 2018. Consulting fees make up the largest share, 85% of the total. Accelerate Diagnostics Inc. paid the most, $7,980.

Dmand AI lists 14 awards for Dr. Uslan, most recently CMS Stage 1 EHR in 2013.

Dr. Uslan graduated from Keck School of Medicine of USC in 2001.

Dr. Uslan is in network with 7 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.